ema glp-1 vision loss recommendation 2025 Glucagon-like peptide-1 receptor agonists: What ophthalmologists need to know European Medicines Agency Investigating GLP-1

32 Cold or room-temperature foods may be better tolerated due to reduced aroma

In a 12-week study that included 120 overweight and obese individuals from the Lebanese population, participants were divided into four groups, receiving either 5, 10, or 15ml of ACV daily, or a placebo

In the semaglutide group, 569 out of 8803 patients (6.5%) experienced a primary cardiovascular end-point event, compared to 701 out of 8801 patients (8.0%) in the placebo group (hazard ratio, 0.80

K.HadjichrysanthouC.GrasL.GoudsmitJ.AndersonR

Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist

This approach prioritises long-term skin health over short-term visual payoff, a shift that reflects a broader evolution in how skincare is being formulated and understood